Oruen CNS Weekly Roundup: Latest Findings Across CNS Medicine

Latest Research and Developments Across CNS Medicine

This week’s Oruen CNS Weekly Roundup highlights recent developments across epilepsy, stroke rehabilitation, neurointervention, neuro-oncology, neurodegeneration and neurocritical care. The selection explores emerging rehabilitation technologies, advances in neurological monitoring, clinical decision-making and potential biomarkers for neurological disease.

⸻

Epilepsy / Paediatric Neurology

New Review Highlights the Substantial Burden of Developmental and Epileptic Encephalopathies Beyond Seizures

A recent review published in Frontiers in Neurology examines the wider clinical impact of developmental and epileptic encephalopathies (DEEs), a group of severe neurological disorders frequently associated with early-onset seizures and neurodevelopmental impairment.

The authors highlight that seizure frequency alone does not adequately reflect the burden of these conditions. Cognitive difficulties, behavioural problems, developmental impairment and the effects on families and caregivers represent important aspects of DEEs.

The review supports a more comprehensive approach to clinical assessment and treatment, incorporating developmental outcomes, quality of life and family wellbeing alongside seizure management.

Hyperlink:
⁠https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1960314/full

⸻

Stroke / Neurorehabilitation

Randomised Trial Investigates Combined Auditory Stimulation and Treadmill Training to Improve Walking After Stroke

A randomised controlled trial published in Frontiers in Neurology investigated whether combining rhythmic auditory stimulation with split-belt treadmill training could improve walking performance in patients with post-stroke hemiparesis.

The intervention was designed to address abnormalities in gait timing, symmetry and coordination by combining external rhythmic cues with treadmill-based motor training.

The researchers reported improvements in spatiotemporal gait parameters, suggesting that integrating auditory stimulation with targeted locomotor rehabilitation may offer additional opportunities to improve walking performance after stroke.

Hyperlink:
⁠https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1904812/full

⸻

Neurointervention / Acute Ischaemic Stroke

New Clinical Score Proposed to Support Thrombectomy Decisions in Basilar Artery Occlusion

Researchers have proposed a simplified clinical assessment tool, known as the HALF-IT score, to support treatment decisions for patients presenting with basilar artery occlusion.

Basilar artery occlusion is a potentially devastating form of posterior circulation stroke, and identifying patients most likely to benefit from mechanical thrombectomy remains an important clinical challenge.

The proposed score aims to simplify patient assessment and provide clinicians with additional information when evaluating candidates for endovascular treatment. Further external validation is necessary before the score can be recommended for routine clinical use.

Hyperlink:
⁠https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1915436/full

⸻

Neuro-oncology / Immunotherapy

New Review Outlines Improved Neurological Monitoring for Patients Receiving CAR T-Cell Therapy

A review published in Frontiers in Neurology examines the recognition and management of immune effector cell-associated neurotoxicity syndrome (ICANS), a potentially serious neurological complication of CAR T-cell therapy and CD3-engaging bispecific antibodies.

Drawing on 26 studies, the authors recommend structured neurological assessment before treatment, regular bedside monitoring and targeted use of electroencephalography and neuroimaging when clinically indicated.

The review also highlights differences in neurotoxicity patterns between CAR T-cell therapies and bispecific antibodies, including the possibility of delayed movement and cognitive syndromes following certain treatments.

The findings reinforce the importance of involving neurologists in multidisciplinary cancer care and developing treatment-specific monitoring pathways.

Hyperlink:
⁠https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1903348/full

⸻

Neurodegeneration / Amyotrophic Lateral Sclerosis

Wearable Robotic Technology Investigated for Improving Mobility and Quality of Life in ALS

A study published in Frontiers in Neurology investigated the use of Hybrid Assistive Limb (HAL) technology in patients with amyotrophic lateral sclerosis (ALS).

HAL is a wearable robotic system designed to support voluntary movement by detecting bioelectrical signals associated with muscle activation and providing corresponding mechanical assistance.

Researchers evaluated the technology’s potential to support walking ability and quality of life in people living with ALS, a progressive neurodegenerative condition characterised by muscle weakness and declining mobility.

The findings contribute to growing research into assistive robotics and personalised rehabilitation for neurological disorders, although larger controlled studies are needed to establish the extent and durability of any clinical benefits.

Hyperlink:
⁠https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1823485/full

⸻

Neurocritical Care / Neurological Biomarkers

Inflammatory Cell-Death Pathways Identify Potential Blood Biomarker for Sepsis-Associated Encephalopathy

Researchers have investigated the relationship between immune-mediated programmed cell death and sepsis-associated encephalopathy, a neurological complication of severe systemic infection.

The study identified soluble tumour necrosis factor receptor 1 (sTNFR1) as a potential circulating biomarker associated with inflammatory pathways implicated in neurological dysfunction.

The findings suggest that integrating molecular markers of inflammation and programmed cell death could eventually improve understanding of sepsis-related brain injury and support the development of more targeted diagnostic approaches.

However, the clinical utility of sTNFR1 for identifying or predicting sepsis-associated encephalopathy requires further validation.

Hyperlink:
⁠https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1954784/full

⸻